Dual Function of VPO1 in Pathogen Recognition and Killing

VPO1在病原体识别和杀灭中的双重功能

基本信息

  • 批准号:
    8536724
  • 负责人:
  • 金额:
    $ 17.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Innate immunity is broadly defined as the first line of defense against invading pathogens. Innate immune recognition is classically mediated by the interaction of pattern-recognition receptors (PRRs) and pathogen-associated molecular patterns (PAMPs), triggering serial downstream signaling events; alternatively, a number of enzymes such as lysozyme, digestive enzymes and defensins indiscriminately kill bacteria when the enzyme encounters the microbes. In the latter case, the enzyme does not directly recognize microbes, and the elimination of invading microbes is non-specific. Whether there is a PRR to directly kill invading microorganisms remains to be elucidated. Vascular peroxidase 1 (VPO1) is a newly-discovered mammalian heme-containing peroxidase (hPx). VPO1 is unique among the members of hPx family in that it contains a catalytic domain at its C-terminus and a large N-terminal region including five leucine-rich regions (LRRs) and four immunoglobulin (Ig) C2 type domains. VPO1 is highly expressed in the cardiovascular system, lung, liver, pancreas and spleen, and is secreted into bloodstream at a 1000-fold higher concentration than is MPO. However, its biological function has not been established. The central hypothesis of this proposed research is that VPO1 can recognize and directly kill invading microbes. Our specific aims are to (1) determine whether the LRR and Ig C2 domains of VPO1 bind to PAMPs; (2) determine if the binding of VPO1, via LRR and Ig C2, mediates microbicidal activity via generation of hypohalous acids. The major methods for addressing the aims include molecular cloning and expressing, protein purification, fluorescence polarization technology and surface plasmon resonance technology. Successful completion of this proposal will: (1) provide novel insights into innate immune responses; (2) identify the first mammalian protein with dual functions of pathogen recognition and killing; (3) create a new paradigm in the maintenance of bloodstream sterility by the physiological action of a novel dual function hPx; (4) elucidate the molecular mechanisms of VPO1-mediated pathogen recognition and killing, setting the foundation for the future development of diagnostics and/or therapeutics involving this novel innate immune pathway.
描述(由申请人提供):先天免疫被广泛定义为抵抗入侵病原体的第一道防线。先天免疫识别通常由模式识别受体(PRR)和病原体相关分子模式(PAMP)的相互作用介导,触发一系列下游信号传导事件;或者,当酶遇到微生物时,许多酶如溶菌酶、消化酶和防御素不加选择地杀死细菌。在后一种情况下,酶不直接识别微生物,并且入侵微生物的消除是非特异性的。是否存在直接杀死入侵微生物的PRR仍有待阐明。血管过氧化物酶1(VPO 1)是一种新发现的哺乳动物血红素过氧化物酶(hPx)。VPO 1在hPx家族成员中是独特的,因为它在其C-末端包含催化结构域,并且在其N-末端区域包含五个富含亮氨酸的区域(LRR)和四个免疫球蛋白(IG)C2型结构域。VPO 1在心血管系统、肺、肝、胰腺和脾中高度表达,并且以比MPO高1000倍的浓度分泌到血流中。然而,其生物学功能尚未确定。这项研究的核心假设是VPO 1可以识别并直接杀死入侵的微生物。我们的具体目标是(1)确定VPO 1的LRR和IG C2结构域是否与PAMP结合;(2)确定VPO 1通过LRR和IG C2的结合是否通过产生次卤酸介导杀微生物活性。主要的方法有分子克隆与表达、蛋白纯化、荧光偏振技术和表面等离子体共振技术。该方案的成功完成将:(1)为先天免疫反应提供新的见解;(2)鉴定第一个具有病原体识别和杀灭双重功能的哺乳动物蛋白;(3)通过新型双功能hPx的生理作用在维持血流无菌性方面创造新的范例;(4)阐明VPO 1介导的病原体识别和杀伤的分子机制,为涉及这种新型先天免疫途径的诊断和/或治疗的未来发展奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guangjie Cheng其他文献

Guangjie Cheng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guangjie Cheng', 18)}}的其他基金

The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
LPS 结合蛋白血管过氧化物酶 1 在先天免疫中的作用
  • 批准号:
    10320902
  • 财政年份:
    2019
  • 资助金额:
    $ 17.27万
  • 项目类别:
Dual Function of VPO1 in Pathogen Recognition and Killing
VPO1在病原体识别和杀灭中的双重功能
  • 批准号:
    8355117
  • 财政年份:
    2012
  • 资助金额:
    $ 17.27万
  • 项目类别:
A novel peroxidase in vascular endothelium and the development of atherosclerosis
血管内皮中的新型过氧化物酶与动脉粥样硬化的发展
  • 批准号:
    7888332
  • 财政年份:
    2008
  • 资助金额:
    $ 17.27万
  • 项目类别:
A novel peroxidase in vascular endothelium and the development of atherosclerosis
血管内皮中的新型过氧化物酶与动脉粥样硬化的发展
  • 批准号:
    8284338
  • 财政年份:
    2008
  • 资助金额:
    $ 17.27万
  • 项目类别:
A novel peroxidase in vascular endothelium and the development of atherosclerosis
血管内皮中的新型过氧化物酶与动脉粥样硬化的发展
  • 批准号:
    7633185
  • 财政年份:
    2008
  • 资助金额:
    $ 17.27万
  • 项目类别:
A novel peroxidase in vascular endothelium and the development of atherosclerosis
血管内皮中的新型过氧化物酶与动脉粥样硬化的发展
  • 批准号:
    7462234
  • 财政年份:
    2008
  • 资助金额:
    $ 17.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了